Table 1.
Distribution of STOML2 expression in cervical cancer patients according to clinicopathologic characteristics
| Charecrestic | No. | STOML2 | P | |
|---|---|---|---|---|
|
| ||||
| + | - | |||
| Age (y) | 0.762 | |||
| ≤ 40 | 44 | 26 | 18 | |
| > 40 | 50 | 28 | 22 | |
| FIGO Stage | 0.013 | |||
| IB | 62 | 30 | 32 | |
| > IB | 32 | 24 | 8 | |
| Tumor size | 0.025 | |||
| ≤ 4 cm | 57 | 38 | 19 | |
| > 4 cm | 37 | 16 | 21 | |
| Differentiation | 0.356 | |||
| Grade 1/2 | 38 | 24 | 14 | |
| Grade 3 | 56 | 30 | 26 | |
| LN Metastasis | 0.808 | |||
| No | 73 | 41 | 32 | |
| Yes | 21 | 13 | 9 | |
| Total NO. of patients | 94 | 54 | 40 | |